Has Steven Carsons, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,172 in general payments to Steven Carsons, MD across 17 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Carsons, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Carsons, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Carsons, MD

Rheumatology · Mineola, NYNPI 1851372817

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,140 of the $12,172 with a category attached, or 83.3%. Novartis accounts for 80.7% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $11,287, more than ten times the $151 reported in 2019.

$12,172in general payments, 2019–2025

Across 17 payments — averaging $716.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$10K
Amgen$1K
Vertex$890

$461,161in research payments, 2019–2025

Across 36 payments — averaging $12,810 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$341K
E.r. Squibb & Sons, L.L.C.$111K
GSK$9K
Amgen$292

What the payments were for

Consulting fees$10,14083%
Travel & lodging$1,33411%
Food & beverage$6986%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	9	$9,821
Amgen(2 entities)	5	$1,461
Vertex	3	$890

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KRYSTEXXA$123

How this compares

$12,172 in reported general payments places this provider in the 75th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York →

Medicare billing

Part B allowed, 2024

$50,425

Medicare patients

145

Services billed

1,753

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50	14	$74,535
Hydroxychloroquine Sulfate	25	$929
MethotrexateMethotrexate Sodium	28	$799
Prednisone	31	$452
Celecoxib	14	$320
Meloxicam	17	$23

Paid to pharmacies, not to this prescriber.

Other rheumatology in Mineola

Gary RosenblumMineola$197K
Laurie GlimcherNew York$3.9M
Grace WrightNew York$3M
Kostas BotsoglouCheektowaga$2.6M
Sergio SchwartzmanNew York$2.5M
Allan GibofskyNew York$1.9M
Petros EfthimiouNew York$791K
Richard FurieNew Hyde Park$746K
Barry GruberBabylon$742K
Olga PetrynaNew York$509K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →